BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16175651)

  • 1. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children?
    Bilge I; Sirin A; Agachan B; Emre S; Sadikoglu B; Yilmaz H; Sucu A; Isbir T
    Cell Biochem Funct; 2007; 25(2):159-65. PubMed ID: 16175651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population.
    Arpaci A; Görmüs U; Dalan B; Berkman S; Isbir T
    In Vivo; 2009; 23(3):421-4. PubMed ID: 19454508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase 192 polymorphism and its relationship to serum lipids in Turkish renal transplant recipients.
    Agachan B; Yilmaz H; Isbir T; Akoglu E
    Transplant Proc; 2004 Jun; 36(5):1385-6. PubMed ID: 15251338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population.
    Kucukali CI; Aydin M; Ozkok E; Orhan N; Cakir U; Kilic G; Ozbek Z; Ince N; Kara I
    Psychiatr Genet; 2008 Dec; 18(6):289-94. PubMed ID: 19018234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PON1 55/192 polymorphism, oxidative stress, type, prognosis and severity of stroke.
    Aydin M; Gencer M; Cetinkaya Y; Ozkok E; Ozbek Z; Kilic G; Orken C; Tireli H; Kara I
    IUBMB Life; 2006 Mar; 58(3):165-72. PubMed ID: 16766384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
    Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
    Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura.
    Yilmaz A; Emre S; Agachan B; Bilge I; Yilmaz H; Ergen A; Isbir T; Sirin A
    J Nephrol; 2009; 22(6):726-32. PubMed ID: 19967651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer.
    Oztürk O; Kağnici OF; Oztürk T; Durak H; Tüzüner BM; Kisakesen HI; Cakalir C; Isbir T
    Anticancer Res; 2009 Oct; 29(10):4041-6. PubMed ID: 19846948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.
    Kafadar AM; Ergen A; Zeybek U; Agachan B; Kuday C; Isbir T
    Cell Biochem Funct; 2006; 24(5):455-60. PubMed ID: 16142697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease].
    Gamboa R; Regalado JC; Huesca-Gómez C; Posadas-Romero C; Verdejo Paris J; Vargas-Alarcón G; Pérez-Méndez O
    Arch Cardiol Mex; 2008; 78(4):360-8. PubMed ID: 19205543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
    Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
    Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
    Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population.
    Aksoy-Sagirli P; Cakmakoglu B; Isbir T; Kaytan-Saglam E; Kizir A; Topuz E; Berkkan H
    Anticancer Res; 2011 Jun; 31(6):2225-9. PubMed ID: 21737645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.